ArticleBioMed research international2026
Clinical Prediction of Posttreatment Migraine Recurrence Using Biofeedback Data: A Machine Learning Framework for Enhanced Patient Stratification and Treatment Monitoring.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Prediction of Posttreatment Migraine Recurrence Using Biofeedback Data: A Machine Learning Framework for Enhanced Patient Stratification and Treatment Monitoring.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Migraine is a complex neurological disorder with significant implications for individual well-being and public health. Predicting migraine occurrences after treatment is crucial for evaluating therapeutic efficacy and enabling personalized care, yet remains largely underexplored. This study proposes a robust machine learning framework to predict posttreatment migraine headache occurrences using real-world headache log data collected from 133 patients undergoing biofeedback therapy. The methodology includes rigorous data preprocessing, outlier removal via the interquartile range (IQR) method, and class imbalance correction through the synthetic minority oversampling technique (SMOTE). A total of 10 classical and a hybrid ensemble machine learning models were developed and optimized through GridSearch with fivefold cross-validation. Performance was evaluated using different metrics, with the best-performing hybrid ensemble model achieving an accuracy and F1-score of 81%, with an area under the receiver operating characteristic curve (AUROC) of 0.87. Additionally, permutation feature importance analysis was employed to enhance model interpretability, identifying medication status, duration of treatment, and patient age as critical predictors. These outcomes validate the prospect of explainable AI-driven models in forecasting migraine recurrence posttreatment, providing a step forward toward intelligent clinical decision support systems for migraine management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.